Evidence map›Paper›PMID 35210565›Full record

ArticleHypertension research : official journal of the Japanese Society of Hypertension2022

Clinical characteristics of older adults with hypertension and unrecognized cognitive impairment.

Koichi Yamamoto, Hiroshi Akasaka, Yukiko Yasunobe, Atsuya Shimizu, Kenichiro Nomoto, Kumiko Nagai, Hiroyuki Umegaki, Yuichi Akasaki, Taro Kojima, Koichi Kozaki and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. The Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (JSH2025).Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  4. Article
  5. Hypertensive dementia and blood pressure management from JSH2025.Hypertension research : official journal of the Japanese Society of Hypertension · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. 2023 update and perspectives.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Review
  10. Article
  11. Is unrecognized cognitive impairment in hypertension unmasked by diabetes mellitus?Hypertension research : official journal of the Japanese Society of Hypertension · 2022
    Article
  12. Preface-Special issue for hypertension in Asia: from the Okinawa declaration to the ISH 2022.Hypertension research : official journal of the Japanese Society of Hypertension · 2022
    Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Koichi Yamamoto *Department of Geriatric and General Medicine, Osaka University Graduate School of Medicine, Osaka, Japan. kyamamoto@geriat.med.osaka-u.ac.jp.
Hiroshi Akasaka *Department of Geriatric and General Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Yukiko YasunobeDepartment of Geriatric and General Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Atsuya ShimizuNational Center for Geriatrics and Gerontology, Obu, Japan.
Kenichiro NomotoNational Center for Geriatrics and Gerontology, Obu, Japan.
Kumiko NagaiDepartment of Geriatric Medicine, Graduate School of Medicine, Kyorin University School of Medicine, Tokyo, Japan.
Hiroyuki UmegakiDepartment of Community Healthcare & Geriatrics, Graduate School of Medicine, Nagoya University, Nagoya, Japan.
Yuichi AkasakiDepartment of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
Taro KojimaDepartment of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Koichi KozakiDepartment of Geriatric Medicine, Graduate School of Medicine, Kyorin University School of Medicine, Tokyo, Japan.
Masafumi KuzuyaDepartment of Community Healthcare & Geriatrics, Graduate School of Medicine, Nagoya University, Nagoya, Japan.
Mitsuru OhishiDepartment of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
Masahiro AkishitaDepartment of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Yoichi TakamiDepartment of Geriatric and General Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Hiromi RakugiDepartment of Geriatric and General Medicine, Osaka University Graduate School of Medicine, Osaka, Japan. rakugi@geriat.med.osaka-u.ac.jp.
Cherry Study Group
Osaka University · JPKagoshima University · JPKyorin University · JPNagoya University · JPNational Center for Geriatrics and Gerontology · JPThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To treat older patients with hypertension, it is important to detect cognitive impairment at an early stage because of its potential influence on treatment efficacy and functional prognosis. In this study, we aimed to identify the incidence and determinants of cognitive impairment in hypertensive patients aged 65 years and above who visited our outpatient clinic and were not previously diagnosed with cognitive impairment. Among 312 patients with hypertension, we found that 35% (n = 109) and 7.7% (n = 24) had cognitive impairment and dementia, respectively, as defined by the Mini-Mental State Examination (≤27 or ≤23, respectively). Patients with cognitive impairment were older, had lower levels of education, and had lower instrumental activities of daily living (IADL) scores than those without cognitive impairment. Multiple regression analysis revealed that age and IADL were associated with cognitive impairment in patients with hypertension. Regarding the treatment of hypertension, the office and home blood pressure levels, number of antihypertensive medications prescribed, and proportion of the use of each antihypertensive drug was equivalent between patients with and without cognitive impairment. Finally, patients with unrecognized cognitive impairment showed distinct clinical characteristics, including high antihypertensive medication burden and preserved IADL, when compared to hypertensive patients in the different cohorts of definitive mild cognitive impairment of a similar age. These findings suggest that older hypertensive patients are at a high risk of masked cognitive decline, even if they are functionally independent.

Indexed as

Cognitive DysfunctionHypertensionActivities of Daily LivingAgedAntihypertensive AgentsEducational StatusHumansAntihypertensive AgentsCognitive impairmentHypertensionMild cognitive impairmentOutpatient clinic

Identifiers

PMID35210565
OpenAlexW4213448516

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.